Kiran Ahluwalia

Kiran Ahluwalia is a seasoned scientist with extensive experience in antibody discovery and engineering. Currently serving as a Senior Principal Scientist at Tizona Therapeutics, Inc. since February 2017, Kiran built a phage display group and played a crucial role in optimizing lead programs. Prior to this, Kiran was a Scientist II at XOMA from August 2005 to December 2016, focused on discovering and engineering therapeutic antibodies. Kiran's earlier positions include Associate Scientist at Abgenix, where the characterization of monoclonal antibodies was key, and Chemist at Microgenics, concentrating on antibody purification and modification. Kiran began a career in analytical chemistry at Cerus Corporation, conducting stability studies and method development. Educational credentials include a Master's Degree in Botany/Plant Physiology from Punjab Agricultural University.